FostaMatinib DisodiuM Hexahydrate

CAS914295-16-2

FostaMatinib DisodiuM Hexahydrate (CAS 914295-16-2, C23H28FN6NaO10P) is supplied by ChemSigma for research and manufacturing, with specification, analytical methods and batch documentation available on request.

Chemical structure of FostaMatinib DisodiuM Hexahydrate
C23H28FN6NaO10P · 642.43 g/mol
CAS No.
914295-16-2
Formula
C23H28FN6NaO10P
Mol. weight
642.43 g/mol

Chemical Specifications

Identifiers

CAS number 914295-16-2
Product name FostaMatinib DisodiuM Hexahydrate
Chinese name 6-[[5-氟-2-[(3,4,5-三甲氧基苯基)氨基]-4-嘧啶基]氨基]-2,2-二甲基-4-[(磷酰氧)甲基]-2H-吡啶并[3,2-B]-1,4-恶嗪-3(4H)-酮二钠盐六水合物
Chinese synonyms 6-[[5-氟-2-[(3,4,5-三甲氧基苯基)氨基]-4-嘧啶基]氨基]-2,2-二甲基-4-[(磷酰氧)甲基]-2H-吡啶并[3,2-B]-1,4-恶嗪-3(4H)-酮二钠盐六水合物
Molecular formula C23H28FN6NaO10P
Molecular weight 642.43 g/mol

Packaging, Storage & Transport

Available pack sizes 5kg, 1kg, 500g, 100g, 50g, 10g

Read the current safety data sheet before handling. Packaging can be adapted to the order quantity and destination.

Frequently Asked Questions

What is the CAS number of FostaMatinib DisodiuM Hexahydrate?

The CAS Registry Number of FostaMatinib DisodiuM Hexahydrate is 914295-16-2.

What is the molecular formula and molecular weight of FostaMatinib DisodiuM Hexahydrate?

The molecular formula of FostaMatinib DisodiuM Hexahydrate is C23H28FN6NaO10P, and its molecular weight is 642.43 g/mol.

How can I request a quotation for FostaMatinib DisodiuM Hexahydrate?

Send an inquiry for FostaMatinib DisodiuM Hexahydrate (CAS 914295-16-2) with the required quantity, target specification, destination country and any documentation requirements. ChemSigma will confirm availability, packaging, lead time and price.

Request a Quote for FostaMatinib DisodiuM Hexahydrate

Tell us the required quantity, target specification, destination country and any documentation requirements. We will confirm availability, packaging, lead time and price.

Need custom synthesis or scale-up? Our group company CKS Technology offers custom synthesis, process development and scale-up.